India · Delayed Price · Currency is INR Alkem Laboratories Statistics
Total Valuation
NSE:ALKEM has a market cap or net worth of INR 641.82 billion. The enterprise value is 626.97 billion.
| Market Cap | 641.82B |
| Enterprise Value | 626.97B |
Important Dates
The last earnings date was Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | Aug 7, 2026 |
Share Statistics
NSE:ALKEM has 119.57 million shares outstanding. The number of shares has decreased by -0.00% in one year.
| Current Share Class | 119.57M |
| Shares Outstanding | 119.57M |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | -0.04% |
| Owned by Insiders (%) | 43.12% |
| Owned by Institutions (%) | 27.08% |
| Float | 44.48M |
Valuation Ratios
The trailing PE ratio is 29.75 and the forward PE ratio is 26.26. NSE:ALKEM's PEG ratio is 2.66.
| PE Ratio | 29.75 |
| Forward PE | 26.26 |
| PS Ratio | 4.26 |
| PB Ratio | 4.47 |
| P/TBV Ratio | 4.98 |
| P/FCF Ratio | 47.69 |
| P/OCF Ratio | 32.70 |
| PEG Ratio | 2.66 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.02, with an EV/FCF ratio of 46.59.
| EV / Earnings | 29.06 |
| EV / Sales | 4.16 |
| EV / EBITDA | 21.02 |
| EV / EBIT | 23.99 |
| EV / FCF | 46.59 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.14 |
| Debt / EBITDA | 0.69 |
| Debt / FCF | 1.52 |
| Interest Coverage | 16.62 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 16.29% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 5.88% |
| Revenue Per Employee | 7.80M |
| Profits Per Employee | 1.12M |
| Employee Count | 19,346 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:ALKEM has paid 6.66 billion in taxes.
| Income Tax | 6.66B |
| Effective Tax Rate | 23.19% |
Stock Price Statistics
The stock price has decreased by -0.38% in the last 52 weeks. The beta is 0.30, so NSE:ALKEM's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | -0.38% |
| 50-Day Moving Average | 5,529.86 |
| 200-Day Moving Average | 5,546.06 |
| Relative Strength Index (RSI) | 36.15 |
| Average Volume (20 Days) | 120,546 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:ALKEM had revenue of INR 150.81 billion and earned 21.58 billion in profits. Earnings per share was 180.45.
| Revenue | 150.81B |
| Gross Profit | 97.73B |
| Operating Income | 26.16B |
| Pretax Income | 28.70B |
| Net Income | 21.58B |
| EBITDA | 29.26B |
| EBIT | 26.16B |
| Earnings Per Share (EPS) | 180.45 |
Balance Sheet
The company has 40.61 billion in cash and 20.47 billion in debt, with a net cash position of 20.14 billion or 168.47 per share.
| Cash & Cash Equivalents | 40.61B |
| Total Debt | 20.47B |
| Net Cash | 20.14B |
| Net Cash Per Share | 168.47 |
| Equity (Book Value) | 143.49B |
| Book Value Per Share | 1,155.87 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 19.63 billion and capital expenditures -6.17 billion, giving a free cash flow of 13.46 billion.
| Operating Cash Flow | 19.63B |
| Capital Expenditures | -6.17B |
| Depreciation & Amortization | 3.10B |
| Net Borrowing | 2.08B |
| Free Cash Flow | 13.46B |
| FCF Per Share | 112.56 |
Margins
Gross margin is 64.80%, with operating and profit margins of 17.35% and 14.31%.
| Gross Margin | 64.80% |
| Operating Margin | 17.35% |
| Pretax Margin | 19.03% |
| Profit Margin | 14.31% |
| EBITDA Margin | 19.40% |
| EBIT Margin | 17.35% |
| FCF Margin | 9.15% |
Dividends & Yields
This stock pays an annual dividend of 53.00, which amounts to a dividend yield of 0.99%.
| Dividend Per Share | 53.00 |
| Dividend Yield | 0.99% |
| Dividend Growth (YoY) | 17.78% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 0.00% |
| Shareholder Yield | 0.99% |
| Earnings Yield | 3.36% |
| FCF Yield | 2.10% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for NSE:ALKEM is 5,964.80, which is 11.12% higher than the current price. The consensus rating is "Buy".
| Price Target | 5,964.80 |
| Price Target Difference | 11.12% |
| Analyst Consensus | Buy |
| Analyst Count | 20 |
| Revenue Growth Forecast (3Y) | 11.35% |
| EPS Growth Forecast (3Y) | 8.02% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |